BIO-GATE AG (BIG1.DE) Stock Price & Overview
FRA:BIG1 • DE000BGAG981
Current stock price
The current stock price of BIG1.DE is 0.57 EUR. Today BIG1.DE is down by -11.63%. In the past month the price decreased by -4.2%. In the past year, price decreased by -22.97%.
BIG1.DE Key Statistics
- Market Cap
- 5.267M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.15
- Dividend Yield
- N/A
BIG1.DE Stock Performance
BIG1.DE Stock Chart
BIG1.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BIG1.DE. When comparing the yearly performance of all stocks, BIG1.DE is a bad performer in the overall market: 93.19% of all stocks are doing better.
BIG1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIG1.DE. While BIG1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
BIG1.DE Earnings
BIG1.DE Forecast & Estimates
8 analysts have analysed BIG1.DE and the average price target is 3.06 EUR. This implies a price increase of 436.84% is expected in the next year compared to the current price of 0.57.
For the next year, analysts expect an EPS growth of 27.27% and a revenue growth 0.33% for BIG1.DE
BIG1.DE Groups
Sector & Classification
BIG1.DE Financial Highlights
Over the last trailing twelve months BIG1.DE reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 31.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.97% | ||
| ROE | -151.1% | ||
| Debt/Equity | 0 |
BIG1.DE Ownership
BIG1.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SY1 | SYMRISE AG | 18.2 | 10.1B | ||
| AKU1 | AKZO NOBEL N.V. | 12.75 | 8.676B | ||
| AKZA | AKZO NOBEL N.V. | 12.77 | 8.655B | ||
| EVK | EVONIK INDUSTRIES AG | 13.71 | 7.987B | ||
| 1EVK | EVONIK INDUSTRIES AG | 13.57 | 7.861B | ||
| SYENS | SYENSQO SA | 14.11 | 5.404B | ||
| WCH | WACKER CHEMIE AG | 327.76 | 4.714B | ||
| AKE | ARKEMA | 12.65 | 4.628B | ||
| UMI | UMICORE | 12.39 | 4.295B | ||
| NVJP | UMICORE | 12.47 | 4.285B | ||
| RBT | ROBERTET SA | 16.53 | 1.877B | ||
| ACT | ALZCHEM GROUP AG | 29.25 | 1.803B | ||
| CRBN | CORBION NV | 12.93 | 1.106B |
Related stock screener links
View all stocks in the Specialty Chemicals Industry | View all stocks in the Materials Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About BIG1.DE
Company Profile
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
Company Info
IPO: 2006-04-05
BIO-GATE AG
Neumeyerstrasse 28-34
Nuremberg BAYERN DE
Employees: 46
Phone: 49911477523100
BIO-GATE AG / BIG1.DE FAQ
What does BIG1 do?
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
What is the current price of BIG1 stock?
The current stock price of BIG1.DE is 0.57 EUR. The price decreased by -11.63% in the last trading session.
What is the dividend status of BIO-GATE AG?
BIG1.DE does not pay a dividend.
What is the ChartMill rating of BIO-GATE AG stock?
BIG1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for BIO-GATE AG?
BIO-GATE AG (BIG1.DE) operates in the Materials sector and the Chemicals industry.
How is the valuation of BIO-GATE AG (BIG1.DE) based on its PE ratio?
BIO-GATE AG (BIG1.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
How many employees does BIO-GATE AG have?
BIO-GATE AG (BIG1.DE) currently has 46 employees.